Search - tctmd.com

Displaying 861 - 880 of 900

Sort: Relevancy | Date

Presentation

MISTRAL: Prehospital Abciximab in STEMI

Presenter: Patrick Ohlmann

February 09, 2012

Presentation

Statin Therapy is Associated with Superior Clinical Outcomes After Endovascular Treatment of CLI

Presenter: Francesco A. Aiello

January 26, 2012

Presentation

El Tratamiento con Estatinas se Asocia a Mejores Resultados Clínicos Tras Tratamiento Endovascular de la ICE

Presenter: Francesco A. Aiello

January 26, 2012

Presentation

Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor

Presenter: Shaun G. Goodman

January 24, 2012

Presentation

Relaciones entre el uso de IBP y Desenlaces Cardiovasculares con Clopidogrel y Ticagrelor

Presenter: Shaun G. Goodman

January 24, 2012

Presentation

El Tratamiento con Bivalirudina se Asocia a Mejores Resultados Clínicos y Económicos en Pacientes con STEMI Sometidos a PCI

Presenter: Duane S. Pinto

January 18, 2012

Presentation

Bivalirudin Therapy Is Associated with Improved Clinical and Economic Outcomes in STEMI Pts Undergoing PCI

Presenter: Duane S. Pinto

January 18, 2012

Presentation ISET 2012

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Presenter: Gunnar Tepe

January 17, 2012

Presentation ISET 2012

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Presenter: Gregg W. Stone

January 15, 2012

Presentation

Insuficiente Inhibición Plaquetaria asociada a Infartos Cerebrales Embólicos Silenciosos tras Angiografía

Presenter: B.J. Kim

January 12, 2012

Presentation

Insufficient Platelet Inhibition Related to Silent Embolic Cerebral Infarctions After Angiography

Presenter: B.J. Kim

January 12, 2012

Presentation

Relación del Dabigatran con un Mayor Riesgo de Episodios Coronarios Agudos

Presenter: Ken Uchino

January 09, 2012

Presentation

Dabigatran Association with Higher Risk of Acute Coronary Events

Presenter: Ken Uchino

January 09, 2012

Presentation

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events

Presenter: Michael V. Holmes

January 04, 2012

Presentation TCT 2012

The Effect Of Cilostazol On The Antiplatelet Efficacy Of Patients with Moderate Renal Dysfunction: Post-hoc Analysis Of CILON-T (Influence of CILostazol based triple...

Presenter: Min-Ho Lee, Jung-Won Suh, Seung-Pyo Lee, Kyung Woo Park, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Young-Seok Cho, Tae-Jin Youn, In-Ho Chae, Dong-Ju Choi, Seung-Woon Rha, Jang-Ho Bae, Taek-Geun Kwon, Jang-Whan Bae, Myeong-Chan Cho, Hyo-Soo Kim

January 03, 2012

Presentation TCT 2012

Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using...

Presenter: Li-Ming Gan, Ann Wittfeldt, H?kan Emanuelsson, Sven Nylander, Magnus Andersson

January 03, 2012

Presentation TCT 2012

The Controlled Reperfusion with Bivalirudin and Intra Coronary Abciximab in the Porcine Mycoardial Infarction/Reperfusion Model

Presenter: Piotr P. Buszman, Wojciech Wojakowski, Krzystof Milewski, Marcin Debinski, Jacek Pajak, Wanda Jackiewicz, Michal Jelonek, Pawel E. Buszman

January 03, 2012

Presentation TCT 2012

Stopping Clopidogrel 1 year After Drug-Eluting Stent (DES) Implantation: Is It Safe?

Presenter: Nalyaka Sambu, Hazel Dent, Timothy Warner, Nicola Englyst, Philip Leadbeater, Alex Hobson, Alison Calver, Simon Corbett, Huon Gray, Iain Simpson, John Morgan, Nick Curzen

January 03, 2012

Presentation TCT 2012

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Response to Prasugrel in ST Elevation Myocardial Infarction Patients: is it as Rapid as we Expected?

Presenter: Fr?d?ric Casassus, Lionel Leroux, Chloe James, Sali Sidibe, Agnalys Desplantes, David Naibo, Benjamin Seguy, Pierre Chevallereau, Pierre Coste

January 03, 2012

Advertisement

MISTRAL: Prehospital Abciximab in STEMI

Statin Therapy is Associated with Superior Clinical Outcomes After Endovascular Treatment of CLI

El Tratamiento con Estatinas se Asocia a Mejores Resultados Clínicos Tras Tratamiento Endovascular de la ICE

Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor

Relaciones entre el uso de IBP y Desenlaces Cardiovasculares con Clopidogrel y Ticagrelor

El Tratamiento con Bivalirudina se Asocia a Mejores Resultados Clínicos y Económicos en Pacientes con STEMI Sometidos a PCI

Bivalirudin Therapy Is Associated with Improved Clinical and Economic Outcomes in STEMI Pts Undergoing PCI

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

The Use of Alternative Anticoagulants for Cardiac and Vascular Procedures

Insuficiente Inhibición Plaquetaria asociada a Infartos Cerebrales Embólicos Silenciosos tras Angiografía

Insufficient Platelet Inhibition Related to Silent Embolic Cerebral Infarctions After Angiography

Relación del Dabigatran con un Mayor Riesgo de Episodios Coronarios Agudos

Dabigatran Association with Higher Risk of Acute Coronary Events

CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events

The Effect Of Cilostazol On The Antiplatelet Efficacy Of Patients with Moderate Renal Dysfunction: Post-hoc Analysis Of CILON-T (Influence of CILostazol based triple...

Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using...

The Controlled Reperfusion with Bivalirudin and Intra Coronary Abciximab in the Porcine Mycoardial Infarction/Reperfusion Model

Stopping Clopidogrel 1 year After Drug-Eluting Stent (DES) Implantation: Is It Safe?

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Response to Prasugrel in ST Elevation Myocardial Infarction Patients: is it as Rapid as we Expected?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content